Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance. - Fife D; Voss EA; Hardin J; Rofael H; Solomon ID; Ryan PB; Stang P (Neuropsychopharmacology reports, 2021)